Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
ARS Pharmaceuticals Inc
Swot
ARS Pharmaceuticals Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
ARS Pharmaceuticals Inc has 10 Strengths, 8 Weaknesses, 3 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(10)
Weakness
(8)
Opportunity
(3)
Threats
(1)
Others
(1)
Strong Momentum: Price above short, medium and long term moving averages
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over 1 Year
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Companies with Low Debt
Stock with Low PE (PE < = 10)
Volume Shockers
Stocks with Quarter Change % less than Industry
Momentum Trap (DVM)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low durability companies
Top Losers
Profit to Loss Companies
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter
Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts
Mutual Funds Increased Shareholding in Past Month
Institutions increasing their shareholding
MFs decreased their shareholding last quarter
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
